Genpax CEO Julian Hardy Joins Cycling Challenge from Scotland to Rome for Motor Neuron Disease
Our CEO, Julian Hardy, is currently taking part in the 'All Roads Lead to Rome' cycling challenge in support of the 'My Name'5 Doddie...
top of page
.jpg)
Winners of the 2023 IET Health Technology award
Connecting Pathogen Genomics
Genpax is revolutionizing the way bacteria and their antimicrobial resistances are tracked across the world
Genpax's analysis platform, IDEM, is the highest-resolution, globally connectable, whole genome sequencing surveillance tool for infectious diseases
An estimated 7.7 million deaths are associated with bacterial infections annually at a significant cost to the global economy.
The steady rise of antimicrobial resistance indicates a regression to pre-antibiotic times, forecasting 10 million annual deaths by 2050.
IDEM analyses and interrogates whole genome sequencing data to inform and connect healthcare and public health to contain and curtail outbreaks
Our mission is to provide the highest quality analysis and deliver a global solution in the fight against bacteria
bottom of page